Compare FATE & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FATE | MERC |
|---|---|---|
| Founded | 2007 | 1968 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.8M | 106.5M |
| IPO Year | 2013 | 1987 |
| Metric | FATE | MERC |
|---|---|---|
| Price | $1.07 | $2.45 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $3.92 | $3.00 |
| AVG Volume (30 Days) | ★ 1.5M | 730.5K |
| Earning Date | 11-13-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 6.22% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,137,000.00 | ★ $1,906,971,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $1.48 |
| 52 Week High | $1.94 | $8.28 |
| Indicator | FATE | MERC |
|---|---|---|
| Relative Strength Index (RSI) | 51.95 | 71.59 |
| Support Level | $0.97 | $1.93 |
| Resistance Level | $1.13 | $2.07 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 63.69 | 90.53 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.